Related Experiment Videos
Liver transplantation and hepatitis viruses
R Williams1, J G O'Grady, S E Davies
1Institute of Liver Studies, King's College School of Medicine and Dentistry, Denmark Hill, London, UK.
Archives of Virology. Supplementum
|January 1, 1992
Summary
Liver transplantation is crucial for acute liver failure and chronic liver disease caused by viral hepatitis. Prognosis, indications, and reinfection risks guide transplant decisions, alongside immunoprophylaxis and antiviral treatments.
Area of Science:
- Hepatology
- Transplantation Medicine
- Virology
Background:
- Viral hepatitis is a leading cause of acute liver failure (ALF) and end-stage chronic liver disease (CLD).
- Liver transplantation is a life-saving option for patients with decompensated liver disease or ALF unresponsive to medical management.
- Reinfection of the graft is a significant concern following liver transplantation for viral hepatitis.
Purpose of the Study:
- To review the key considerations for liver transplantation in patients with viral hepatitis-related ALF and CLD.
- To outline prognostic parameters and indications for liver transplantation in this patient population.
- To discuss strategies for preventing graft reinfection and managing post-transplant outcomes.
Main Methods:
- Review of existing literature on liver transplantation for viral hepatitis.
- Analysis of prognostic factors influencing transplant outcomes.
- Evaluation of immunoprophylaxis and antiviral therapy protocols.
Main Results:
- Specific prognostic indicators and transplant indications vary based on the causative viral agent.
- The risk of graft reinfection differs significantly among hepatitis viruses (e.g., Hepatitis B vs. Hepatitis C).
- Immunoprophylaxis and antiviral treatments (like interferon) play a critical role in preventing recurrence and improving long-term graft survival.
Conclusions:
- Liver transplantation is a viable treatment for select patients with viral hepatitis-induced liver failure.
- Careful patient selection, risk assessment for reinfection, and tailored peri- and post-transplant management are essential.
- Prophylactic strategies, including immunoprophylaxis and antiviral therapy, are crucial for successful outcomes in liver transplantation for viral hepatitis.